Add BrightSurf on Google Email

A more complete molecular picture of lung squamous cell carcinoma comes into view

A comprehensive molecular map of lung squamous cell carcinoma has identified potential new drug targets, including the gene NSD3, and highlighted immune regulation pathways that could help cancer evade immunotherapies. The study's findings have also revealed metabolic dysregulation and crosstalk between different cellular processes.

SourceBroad Institute of MIT and Harvard·JournalCell·TypeComputational simulation/modeling·DateAug 5, 2021

Organ transplant recipients significantly protected by COVID-19 vaccination

A recent study published in Transplant Infectious Disease found that COVID-19 vaccination provides strong protection against the virus for solid organ transplant recipients, with an almost 80% reduction in symptomatic cases. The study examined data from over 2,150 transplant patients and showed that nearly 70% of vaccinated patients re...

SourceUniversity of California - San Diego·JournalTransplant Infectious Disease·DateAug 5, 2021
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Potential biomarker found for lung disease in scleroderma patients

Researchers discovered a protein called CTRP9 associated with pulmonary function in scleroderma patients with interstitial lung disease. Patients with higher CTRP9 levels developed more severe lung disease, while low levels were linked to preserved function. The study suggests CTRP9 could help predict treatment needs for these patients.

SourceMichigan Medicine - University of Michigan·TypeData/statistical analysis·DateAug 3, 2021

CHEST releases new guidelines for antithrombotic therapy for VTE disease

The American College of Chest Physicians has released new clinical guidelines for venous thromboembolism (VTE) management, providing 29 recommendations on patient care and treatment. The guidelines update previous recommendations and offer strong guidance for clinicians managing patients with VTE.

SourceAmerican College of Chest Physicians·JournalCHEST Journal·DateAug 3, 2021

New study yields insights into chronic rejection after lung transplantation

Researchers identified protein patterns in lung tissue from patients with end-stage bronchiolitis obliterans syndrome, revealing an epithelial/mesenchymal imbalance and increased stiffness in remodeled airways. This breakthrough study may help develop therapies to improve long-term outcomes for lung transplantation patients.

SourceElsevier·JournalAmerican Journal Of Pathology·TypeExperimental study·DateAug 3, 2021

Enabling safe delivery of RNA drugs to the lungs

Researchers at Hokkaido University created a lipid polymer that can carry genetic code into lung cells, potentially treating diseases such as acute respiratory distress syndrome and lung cancers. The delivery method bypasses the liver and targets specific lung cells without targeting ligands.

SourceHokkaido University·JournalMaterials Horizons·TypeExperimental study·DateJul 30, 2021
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

UIC awarded $6 million to develop potential COVID-19 treatment

Researchers at UIC are developing a potential COVID-19 treatment using VT-109, which has shown promise in animal models by restoring lung function and reducing inflammation. The new funding will be used to conduct pre-clinical studies to determine efficacy, toxicity, and dosages before human trials.

SourceUniversity of Illinois Chicago·DateJul 28, 2021

A breath of fresh air for emphysema research

A team of researchers identified a protein called FCHSD1 involved in COPD-related inflammation and cell death. Mice lacking FCHSD1 showed reduced inflammation and apoptosis, suggesting its inhibition as a potential therapy for emphysema.

SourceTokyo Medical and Dental University·JournalProceedings of the National Academy of Sciences·DateJul 19, 2021

Firefighters found to have persistent lung damage from Fort McMurray wildfire

A University of Alberta research team found that firefighters dealing with the massive 2016 Fort McMurray wildfire suffered from long-term lung damage, including increased bronchial reactivity and thickening. The risk of developing asthma was more than doubled compared to the general population.

SourceUniversity of Alberta Faculty of Medicine & Dentistry·JournalJournal of Occupational and Environmental Medicine·DateJul 19, 2021

Cellular push and pull, a key to the body's response to processes such as cancer

Researchers discovered that cells sense and respond to mechanical forces based on the rate of force application, which can lead to cell stiffening or softening. The 'molecular clutch' model explains how this affects cellular behavior, particularly in cancer development and organ function.

SourceInstitute for Bioengineering of Catalonia (IBEC)·JournalNature Communications·DateJul 16, 2021

The cells combating a deadly lung disease

A subset of fibroblasts in lungs of people with idiopathic pulmonary fibrosis (IPF) produce a protein called meflin, which protects against cell aging and fibrosis. Further research could lead to novel therapies for lung fibrosis.

SourceNagoya University·JournalEuropean Respiratory Journal·DateJul 15, 2021
Garmin GPSMAP 67i with inReach

Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.

Like priming a pump, cells damaged by chronic lung disease can result in severe COVID

A TGen-led international study reveals that SARS-CoV-2 takes advantage of genetic changes in patients with pre-existing lung diseases, leading to more severe symptoms and poorer outcomes. The research identifies molecular characteristics associated with worse COVID-19 outcomes, highlighting the need for targeted treatments.

SourceThe Translational Genomics Research Institute·JournalNature Communications·DateJul 14, 2021
Rigol DP832 Triple-Output Bench Power Supply

Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.

Inside the lungs, a new hope for protection against flu damage

Researchers have identified DAF as a receptor that increases damage to the lungs in mice infected with influenza A virus. The study highlights an immune evasion strategy by the virus and stresses the importance of a balanced immune response to viral infections.

SourceInstituto Gulbenkian de Ciencia·JournalPLOS Pathogens·DateJul 2, 2021

Chasing the cells that predict death from severe COVID-19

Researchers discovered fundamental differences in T-cell responses between patients who recover from and die from severe COVID-19. They found that dying patients harbor more lung-homing T cells, which contribute to extensive lung deterioration, while survivors have a growing number of Th1 T cells, important fighters of viral infection.

SourceGladstone Institutes·JournalCell Reports·DateJul 1, 2021
Meta Quest 3 512GB

Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.

Researchers discover unique 'spider web' mechanism that traps, kills viruses

Immunologists at McMaster University have identified a 'spider web' mechanism that traps pathogens like influenza and SARS-CoV-2 in neutrophils, creating a sticky tangle to kill viruses. This discovery could lead to new aerosol and nasal spray vaccine technologies to prevent infections before they spread.

SourceMcMaster University·JournalProceedings of the National Academy of Sciences·DateJun 29, 2021

Vaping increases susceptibility to coronavirus in mice

Research from Thomas Jefferson University found that e-cigarette vapor increases levels of the coronavirus receptor ACE-2 in lung tissue of mice, making them more susceptible to infection. Male mice were found to have a greater increase in ACE-2 when exposed to nicotine, highlighting a potential sex difference in vaping-related risks.

SourceThomas Jefferson University·JournalJournal of Investigative Medicine·DateJun 29, 2021

Research identifies new ways to try and prevent lethal blood clots

A recent study has made a breakthrough in understanding the process that leads to pulmonary embolism, a condition that kills over 2,000 people in the UK each year. Researchers have identified a protein called fibrin as crucial in stabilizing clots and preventing fragments from breaking loose.

SourceUniversity of Leeds·DateJun 28, 2021
Sky-Watcher EQ6-R Pro Equatorial Mount

Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.

Streptococcus pneumoniae sticks to dying lung cells, worsening secondary infection following flu

Researchers have identified a novel virulence trait of Streptococcus pneumoniae that increases the severity of S. pneumoniae superinfection following flu. The surface protein PspA, previously known to have several other virulence mechanisms, now functions as an adhesin to dying lung epithelial cells. This finding provides further expla...

SourceUniversity of Alabama at Birmingham·JournalCell Reports·DateJun 24, 2021
Davis Instruments Vantage Pro2 Weather Station

Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.

Common antibiotic found useful in accelerating recovery in tuberculosis patients

A Phase 2 trial showed that combining doxycycline with TB treatment reduces lung cavity size and increases markers of recovery in pulmonary TB patients. This discovery has promise for preventing long-term complications and improving outcomes for those affected by the disease.

SourceNational University of Singapore, Yong Loo Lin School of Medicine·JournalJournal of Clinical Investigation·DateJun 19, 2021

'Nanodecoy' therapy binds and neutralizes SARS-CoV-2 virus

Researchers develop nanodecoys made from human lung spheroid cells that bind to and neutralize SARS-CoV-2, accelerating viral clearance and reducing lung injury. The therapy could be effective against emerging variants of the virus.

SourceNorth Carolina State University·JournalNature Nanotechnology·DateJun 17, 2021

Scientists demonstrate promising new approach for treating cystic fibrosis

Researchers at UNC School of Medicine developed an improved oligonucleotide therapy strategy that can correct gene defects underlying cystic fibrosis. The approach has shown promising results in both human cells and mice, with potential applications for treating other pulmonary diseases.

SourceUniversity of North Carolina Health Care·JournalNucleic Acids Research·DateJun 16, 2021
Apple MacBook Pro 14-inch (M4 Pro)

Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.

AI predicts how patients with viral infections, including COVID-19, will fare

A University of California, San Diego study uses AI to analyze gene expression patterns associated with pandemic viral infections. The analysis reveals two telltale signatures that help define patients' immune responses and measure disease severity. These findings provide a map for predicting patient outcomes and testing therapies.

SourceUniversity of California - San Diego·JournalEBioMedicine·DateJun 11, 2021

Common diabetes drug shows promise as treatment for COVID-19 lung inflammation

Researchers found that metformin prevents pulmonary inflammation, a major factor in COVID-19 severity and mortality, by inhibiting inflammasome activation and reducing IL-1β production. Metformin may have therapeutic potential for treating severe COVID-19 and other forms of acute respiratory distress syndrome.

SourceUniversity of California - San Diego·JournalImmunity·DateJun 10, 2021

New heart metric may increase survival for heart-failure patients

A new physiological measurement of heart function, PAPP, has been shown to identify high-risk patients with systolic heart failure or pulmonary hypertension. This monitoring technology can reduce the risk of death by 46% annually in patients with low PAPPs.

SourceUniversity of Virginia Health System·JournalHeart Lung and Circulation·DateJun 8, 2021

How COVID-19 wreaks havoc on human lungs

Scientists at Brookhaven National Laboratory have developed an atomic-level model of the SARS-CoV-2 envelope protein bound to a human lung-cell-junction protein. The findings reveal how the virus causes extensive lung damage by hijacking cell-junction proteins, leading to a cytokine storm and promoting viral spread.

SourceDOE/Brookhaven National Laboratory·JournalNature Communications·DateJun 8, 2021
Creality K1 Max 3D Printer

Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.

Is elevated level of lung protein an early predictor for COPD?

Researchers from UNC School of Medicine discovered that MUC5AC is more reliably associated with COPD manifestation than another mucus protein, revealing a possible biomarker for disease initiation and prognosis. Elevated levels of MUC5AC in non-smokers who developed COPD suggest it could predict disease progression.

SourceUniversity of North Carolina Health Care·JournalThe Lancet Respiratory Medicine·DateJun 3, 2021

How platelets help resolve lung inflammation

Researchers at the University of Münster discovered that platelet-white blood cell interactions resolve lung inflammation by secreting anti-inflammatory substances and eliminating excess neutrophil granulocytes. This finding has implications for developing new therapy concepts to combat acute respiratory failure.

SourceUniversity of Münster·JournalJournal of Experimental Medicine·DateJun 2, 2021
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)

Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.

Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Novel nanotech improves cystic fibrosis antibiotic by 100,000-fold

Researchers have developed a novel nanotechnology that can improve the effectiveness of the CF antibiotic Tobramycin, increasing its efficacy against Pseudomonas aeruginosa lung infections. The technology has shown to eradicate infections in as little as two doses, providing new hope for people living with cystic fibrosis.

SourceUniversity of South Australia·JournalSmall·DateMay 13, 2021

Researchers identify genes responsible for loss of lung function

Researchers at Boston University School of Medicine have identified a panel of genes that are active in smokers and ex-smokers who experience faster loss of lung function. These genes may be useful to predict which people are most at risk for smoking-related decline in lung function, offering hope for early diagnosis and treatment.

SourceBoston University School of Medicine·JournalThorax·DateMay 11, 2021
Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

GQ GMC-500Plus Geiger Counter

GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.

Human mesenchymal stem cells show promise in treating chronic lung infections

Researchers have developed a new model of NTM lung infection and found that human mesenchymal stem cells (hMSCs) are effective in treating this condition. The study identified donor-specific hMSC potency against NTMs, which could lead to improved treatment outcomes for patients with chronic NTM lung disease.

SourceAlphaMed Press·JournalStem Cells Translational Medicine·DateMay 4, 2021

Large collaboration creates cell atlas of COVID-19 pathology

A team of scientists created a cell atlas using autopsy samples from COVID-19 patients, revealing how infected cells and lungs responded to the virus. The study found repeated attempts by the lungs to repair themselves failed due to viral-induced changes in cellular programs.

SourceBroad Institute of MIT and Harvard·JournalNature·DateApr 30, 2021
Fluke 87V Industrial Digital Multimeter

Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.

New cell atlas of COVID lungs reveals why SARS-CoV-2 is deadly and different

Researchers created a detailed cell atlas of COVID lungs, revealing a trifecta of detrimental effects: runaway inflammation, direct destruction, and impaired regeneration of lung cells involved in gas exchange. This study provides leads on why survivors experience long-term respiratory complications due to lung scarring.

SourceColumbia University Irving Medical Center·JournalNature·DateApr 29, 2021

A new treatment that might keep COVID-19 patients off the ventilator

A new treatment has shown promising results in reducing the severity of acute respiratory distress syndrome caused by the flu in mice. The therapy, based on natural molecules, improves lung function and prevents progression of disease in infected animals.

SourceOhio State University·JournalAmerican Journal of Respiratory Cell and Molecular Biology·DateApr 27, 2021
Apple Watch Series 11 (GPS, 46mm)

Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.

E-cigarette users in rural Appalachia develop more severe lung injuries

A recent study from West Virginia University reveals that rural e-cigarette users are more likely to develop severe respiratory failure and require critical care. The study found a high correlation between lung injury and toxic volatile organic compounds in e-liquids, particularly in those produced by garage labs.

SourceWest Virginia University·JournalHospital Practice·DateApr 20, 2021